Serum alpha-fetoprotein (AFP), cancer antigens (CA19-9), and carcinoembryonic antigen (CEA) levels were in patients with primary hepatic cancer (PHC), Liver cirrhosis, and the healthy population can be used as a screening and prognostic tool. The gene discussed is AFP; the disease is cirrhosis of liver.